Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.70)
# 903
Out of 4,412 analysts
258
Total ratings
40.97%
Success rate
9.13%
Average return
Main Sectors:
53 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CORT Corcept Therapeutics | Reiterates: Buy | $38 | $22.80 | +66.67% | 10 | Apr 23, 2024 | |
| LFWD ReWalk Robotics | Reiterates: Buy | $9 | $4.75 | +89.47% | 2 | Apr 15, 2024 | |
| IPHA Innate Pharma | Reiterates: Buy | $12 | $2.46 | +367.48% | 6 | Apr 11, 2024 | |
| ALXO ALX Oncology Holdings | Reiterates: Buy | $20 | $16.86 | +18.62% | 8 | Apr 10, 2024 | |
| INAB IN8bio | Reiterates: Buy | $14 | $1.04 | +1,246.15% | 8 | Apr 10, 2024 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $7 | $4.30 | +62.79% | 3 | Apr 10, 2024 | |
| ELEV Elevation Oncology | Reiterates: Buy | $6 | $3.62 | +65.75% | 4 | Apr 9, 2024 | |
| CLGN CollPlant Biotechnologies | Reiterates: Buy | $11 | $5.89 | +86.76% | 6 | Apr 5, 2024 | |
| ASXC Asensus Surgical | Downgrades: Neutral | $2 → $0.35 | $0.25 | +40.56% | 10 | Apr 4, 2024 | |
| OCGN Ocugen | Reiterates: Buy | $7 | $1.28 | +446.88% | 13 | Apr 3, 2024 | |
| EVAX Evaxion Biotech | Reiterates: Buy | $14 | $4.18 | +234.93% | 3 | Apr 3, 2024 | |
| EDAP EDAP TMS | Maintains: Buy | $19 | $7.28 | +160.99% | 9 | Apr 1, 2024 | |
| AFMD Affimed | Maintains: Buy | $5 → $10 | $5.03 | +98.81% | 7 | Apr 1, 2024 | |
| CALC CalciMedica | Reiterates: Buy | $20 | $5.45 | +266.97% | 1 | Apr 1, 2024 | |
| CELC Celcuity | Reiterates: Buy | $27 | $15.92 | +69.60% | 2 | Mar 28, 2024 | |
| DCTH Delcath Systems | Maintains: Buy | $18 → $20 | $5.30 | +277.36% | 6 | Mar 27, 2024 | |
| XFOR X4 Pharmaceuticals | Reiterates: Buy | $3 | $1.17 | +157.51% | 8 | Mar 22, 2024 | |
| ABSI Absci | Reiterates: Buy | $7 | $4.58 | +52.84% | 6 | Mar 22, 2024 | |
| MDWD MediWound | Reiterates: Buy | $28 | $18.24 | +53.51% | 10 | Mar 22, 2024 | |
| AVGR Avinger | Reiterates: Buy | $5 | $3.73 | +34.04% | 5 | Mar 21, 2024 | |
| VOR Vor Biopharma | Reiterates: Buy | $18 | $1.69 | +935.50% | 7 | Mar 21, 2024 | |
| PGEN Precigen | Reiterates: Buy | $6 | $1.41 | +325.53% | 4 | Mar 20, 2024 | |
| LPTX Leap Therapeutics | Reiterates: Buy | $7 | $3.25 | +115.38% | 6 | Mar 19, 2024 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Buy | $9 | $1.32 | +581.82% | 5 | Mar 15, 2024 | |
| ECOR electroCore | Reiterates: Buy | $15 | $5.76 | +160.42% | 10 | Mar 14, 2024 | |
| JANX Janux Therapeutics | Maintains: Buy | $35 → $50 | $47.39 | +5.51% | 7 | Mar 11, 2024 | |
| ITOS iTeos Therapeutics | Reiterates: Buy | $44 | $10.80 | +307.41% | 5 | Mar 7, 2024 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $10 → $9.25 | $1.25 | +640.00% | 5 | Mar 5, 2024 | |
| VCEL Vericel | Maintains: Buy | $46 → $53 | $46.05 | +15.09% | 10 | Mar 1, 2024 | |
| QSI Quantum-Si incorporated | Maintains: Buy | $3 → $4 | $1.65 | +142.42% | 2 | Mar 1, 2024 | |
| BCYC Bicycle Therapeutics | Maintains: Buy | $57 → $55 | $22.73 | +141.97% | 8 | Feb 21, 2024 | |
| SLDB Solid Biosciences | Initiates: Buy | $9 | $8.98 | +0.22% | 1 | Dec 8, 2023 | |
| TCRT Alaunos Therapeutics | Downgrades: Neutral | n/a | $1.32 | - | 2 | Aug 16, 2023 | |
| PSNL Personalis | Maintains: Buy | $10 → $7.5 | $1.27 | +492.89% | 9 | Aug 9, 2023 | |
| MDXG MiMedx Group | Maintains: Buy | $8 → $11 | $6.27 | +75.44% | 7 | Aug 2, 2023 | |
| CDXS Codexis | Downgrades: Neutral | n/a | $2.66 | - | 10 | May 9, 2023 | |
| LVTX LAVA Therapeutics | Reiterates: Buy | $9 | $2.73 | +229.67% | 1 | Feb 17, 2023 | |
| CELU Celularity | Maintains: Buy | $150 → $25 | $3.02 | +727.81% | 2 | Jan 30, 2023 | |
| PSTX Poseida Therapeutics | Initiates: Buy | $15 | $2.13 | +604.23% | 1 | Jan 4, 2023 | |
| ADAG Adagene | Initiates: Buy | $5 | $2.39 | +109.21% | 1 | Dec 7, 2022 | |
| CLRB Cellectar Biosciences | Maintains: Buy | $3 → $4 | $3.03 | +32.01% | 1 | Nov 4, 2022 | |
| CALA Calithera Biosciences | Upgrades: Buy | $8 | $0.02 | +39,900.00% | 2 | Aug 29, 2022 | |
| CASI CASI Pharmaceuticals | Maintains: Buy | $3 → $12 | $2.42 | +395.87% | 2 | Aug 15, 2022 | |
| BCAB BioAtla | Maintains: Buy | $25 → $20 | $2.54 | +687.40% | 2 | Aug 10, 2022 | |
| PLSE Pulse Biosciences | Downgrades: Neutral | n/a | $7.19 | - | 5 | May 13, 2022 | |
| HOOK HOOKIPA Pharma | Maintains: Buy | $15 → $8 | $0.89 | +795.56% | 4 | Feb 17, 2022 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | n/a | $1.45 | - | 3 | Jul 16, 2021 | |
| INMB INmune Bio | Maintains: Buy | n/a | $11.29 | - | 2 | Jul 15, 2020 | |
| IGXT IntelGenx Technologies | Reiterates: Buy | n/a | $0.16 | - | 1 | Mar 30, 2020 | |
| VSTM Verastem | Maintains: Buy | n/a | $9.38 | - | 1 | Mar 16, 2020 | |
| ATEC Alphatec Holdings | Reiterates: Buy | n/a | $12.44 | - | 2 | Mar 6, 2020 | |
| RDHL RedHill Biopharma | Reiterates: Buy | n/a | $0.43 | - | 1 | Mar 5, 2020 | |
| ADXS Ayala Pharmaceuticals | Downgrades: Neutral | n/a | $0.56 | - | 2 | Dec 18, 2018 |
Corcept Therapeutics
Apr 23, 2024
Reiterates: Buy
Price Target: $38
Current: $22.80
Upside: +66.67%
ReWalk Robotics
Apr 15, 2024
Reiterates: Buy
Price Target: $9
Current: $4.75
Upside: +89.47%
Innate Pharma
Apr 11, 2024
Reiterates: Buy
Price Target: $12
Current: $2.46
Upside: +367.48%
ALX Oncology Holdings
Apr 10, 2024
Reiterates: Buy
Price Target: $20
Current: $16.86
Upside: +18.62%
IN8bio
Apr 10, 2024
Reiterates: Buy
Price Target: $14
Current: $1.04
Upside: +1,246.15%
Pyxis Oncology
Apr 10, 2024
Reiterates: Buy
Price Target: $7
Current: $4.30
Upside: +62.79%
Elevation Oncology
Apr 9, 2024
Reiterates: Buy
Price Target: $6
Current: $3.62
Upside: +65.75%
CollPlant Biotechnologies
Apr 5, 2024
Reiterates: Buy
Price Target: $11
Current: $5.89
Upside: +86.76%
Asensus Surgical
Apr 4, 2024
Downgrades: Neutral
Price Target: $2 → $0.35
Current: $0.25
Upside: +40.56%
Ocugen
Apr 3, 2024
Reiterates: Buy
Price Target: $7
Current: $1.28
Upside: +446.88%
Evaxion Biotech
Apr 3, 2024
Reiterates: Buy
Price Target: $14
Current: $4.18
Upside: +234.93%
EDAP TMS
Apr 1, 2024
Maintains: Buy
Price Target: $19
Current: $7.28
Upside: +160.99%
Affimed
Apr 1, 2024
Maintains: Buy
Price Target: $5 → $10
Current: $5.03
Upside: +98.81%
CalciMedica
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $5.45
Upside: +266.97%
Celcuity
Mar 28, 2024
Reiterates: Buy
Price Target: $27
Current: $15.92
Upside: +69.60%
Delcath Systems
Mar 27, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $5.30
Upside: +277.36%
X4 Pharmaceuticals
Mar 22, 2024
Reiterates: Buy
Price Target: $3
Current: $1.17
Upside: +157.51%
Absci
Mar 22, 2024
Reiterates: Buy
Price Target: $7
Current: $4.58
Upside: +52.84%
MediWound
Mar 22, 2024
Reiterates: Buy
Price Target: $28
Current: $18.24
Upside: +53.51%
Avinger
Mar 21, 2024
Reiterates: Buy
Price Target: $5
Current: $3.73
Upside: +34.04%
Vor Biopharma
Mar 21, 2024
Reiterates: Buy
Price Target: $18
Current: $1.69
Upside: +935.50%
Precigen
Mar 20, 2024
Reiterates: Buy
Price Target: $6
Current: $1.41
Upside: +325.53%
Leap Therapeutics
Mar 19, 2024
Reiterates: Buy
Price Target: $7
Current: $3.25
Upside: +115.38%
ImmunoPrecise Antibodies
Mar 15, 2024
Reiterates: Buy
Price Target: $9
Current: $1.32
Upside: +581.82%
electroCore
Mar 14, 2024
Reiterates: Buy
Price Target: $15
Current: $5.76
Upside: +160.42%
Janux Therapeutics
Mar 11, 2024
Maintains: Buy
Price Target: $35 → $50
Current: $47.39
Upside: +5.51%
iTeos Therapeutics
Mar 7, 2024
Reiterates: Buy
Price Target: $44
Current: $10.80
Upside: +307.41%
Ekso Bionics Holdings
Mar 5, 2024
Maintains: Buy
Price Target: $10 → $9.25
Current: $1.25
Upside: +640.00%
Vericel
Mar 1, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $46.05
Upside: +15.09%
Quantum-Si incorporated
Mar 1, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $1.65
Upside: +142.42%
Bicycle Therapeutics
Feb 21, 2024
Maintains: Buy
Price Target: $57 → $55
Current: $22.73
Upside: +141.97%
Solid Biosciences
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $8.98
Upside: +0.22%
Alaunos Therapeutics
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.32
Upside: -
Personalis
Aug 9, 2023
Maintains: Buy
Price Target: $10 → $7.5
Current: $1.27
Upside: +492.89%
MiMedx Group
Aug 2, 2023
Maintains: Buy
Price Target: $8 → $11
Current: $6.27
Upside: +75.44%
Codexis
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.66
Upside: -
LAVA Therapeutics
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $2.73
Upside: +229.67%
Celularity
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $3.02
Upside: +727.81%
Poseida Therapeutics
Jan 4, 2023
Initiates: Buy
Price Target: $15
Current: $2.13
Upside: +604.23%
Adagene
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.39
Upside: +109.21%
Cellectar Biosciences
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $3.03
Upside: +32.01%
Calithera Biosciences
Aug 29, 2022
Upgrades: Buy
Price Target: $8
Current: $0.02
Upside: +39,900.00%
CASI Pharmaceuticals
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $2.42
Upside: +395.87%
BioAtla
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $2.54
Upside: +687.40%
Pulse Biosciences
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $7.19
Upside: -
HOOKIPA Pharma
Feb 17, 2022
Maintains: Buy
Price Target: $15 → $8
Current: $0.89
Upside: +795.56%
Corvus Pharmaceuticals
Jul 16, 2021
Maintains: Buy
Price Target: n/a
Current: $1.45
Upside: -
INmune Bio
Jul 15, 2020
Maintains: Buy
Price Target: n/a
Current: $11.29
Upside: -
IntelGenx Technologies
Mar 30, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.16
Upside: -
Verastem
Mar 16, 2020
Maintains: Buy
Price Target: n/a
Current: $9.38
Upside: -
Alphatec Holdings
Mar 6, 2020
Reiterates: Buy
Price Target: n/a
Current: $12.44
Upside: -
RedHill Biopharma
Mar 5, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.43
Upside: -
Ayala Pharmaceuticals
Dec 18, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.56
Upside: -